Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SPATA17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GPR158 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BTG4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LDOC1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FOXP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLITRK5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FLJ42627 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRTAP9-4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAMLD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HOPX - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PYGB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IRX3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD29 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101060604 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FMNL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM256-PLSCR3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FRMD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GNA11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDON - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on